Evidence map›Paper›PMID 26606517›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2016

Research Resource: The Dexamethasone Transcriptome in Hypothalamic Embryonic Neural Stem Cells.

Krystle A Frahm, Melanie E Peffer, Janie Y Zhang, Soumya Luthra, Anish B Chakka, Matthew B Couger, Uma R Chandran, A Paula Monaghan, Donald B DeFranco

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. α-Arrestins and Their Functions: From Yeast to Human Health.International journal of molecular sciences · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Krystle A FrahmDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Melanie E PefferDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Janie Y ZhangDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Soumya LuthraDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Anish B ChakkaDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Matthew B CougerDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Uma R ChandranDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
A Paula MonaghanDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Donald B DeFrancoDepartment of Pharmacology and Chemical Biology (K.A.F., J.Y.Z., D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Program in Integrative Molecular Biology (M.E.P., D.B.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biomedical Informatics (S.L., A.B.C., U.R.C.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics (M.B.C.), Oklahoma State University, Stillwater, Oklahoma; and Department of Neurobiology (A.P.M.), University of Pittsburgh, Pittsburgh, Pennsylvania.
University of Pittsburgh · USOklahoma State University · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
EXPANSION OF NURSA TRANSCRIPTOMINE ANNOTATIONU24DK097748 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI EVANS, RONALD M, MCKENNA, NEIL · 2012 to 2017
$9.2M
T32 Research Training in Diabetes and EndocrinologyT32DK007052 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROBERT M O'DOHERTY · 1986 to 2026
$6.3M
PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM008424 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PAGANO, PATRICK J · 1994 to 2019
$3.4M
Selective Glucocorticoid Action in the Developing BrainR01HD087288 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEFRANCO, DONALD B, MONAGHAN-NICHOLS, A PAULA · 2017 to 2021
$2.3M
Intracellular Mechanisms of Glucocorticoid ActionR01DK078394 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEFRANCO, DONALD B · 2007 to 2011
$1.5M
NCI NIH HHS P30 CA047904NCI NIH HHS P30CA047904NICHD NIH HHS L50 HD085229NICHD NIH HHS R01 HD087288NIDDK NIH HHS DK078394NIDDK NIH HHS R01 DK078394NIDDK NIH HHS T32 DK007052NIDDK NIH HHS T32DK007052NIDDK NIH HHS U24 DK097748NIGMS NIH HHS T32 GM008424NIGMS NIH HHS T32GM008424
6 · The paper itself

Abstract

Exposure to excess glucocorticoids during fetal development has long-lasting physiological and behavioral consequences, although the mechanisms are poorly understood. The impact of prenatal glucocorticoids exposure on stress responses in juvenile and adult offspring implicates the developing hypothalamus as a target of adverse prenatal glucocorticoid action. Therefore, primary cultures of hypothalamic neural-progenitor/stem cells (NPSCs) derived from mouse embryos (embryonic day 14.5) were used to identify the glucocorticoid transcriptome in both males and females. NPSCs were treated with vehicle or the synthetic glucocorticoid dexamethasone (dex; 100nM) for 4 hours and total RNA analyzed using RNA-Sequencing. Bioinformatic analysis demonstrated that primary hypothalamic NPSC cultures expressed relatively high levels of a number of genes regulating stem cell proliferation and hypothalamic progenitor function. Interesting, although these cells express glucocorticoid receptors (GRs), only low levels of sex-steroid receptors are expressed, which suggested that sex-specific differentially regulated genes identified are mediated by genetic and not hormonal influences. We also identified known or novel GR-target coding and noncoding genes that are either regulated equivalently in male and female NPSCs or differential responsiveness in one sex. Using gene ontology analysis, the top functional network identified was cell proliferation and using bromodeoxyuridine (BrdU) incorporation observed a reduction in proliferation of hypothalamic NPSCs after dexamethasone treatment. Our studies provide the first characterization and description of glucocorticoid-regulated pathways in male and female embryonically derived hypothalamic NPSCs and identified GR-target genes during hypothalamic development. These findings may provide insight into potential mechanisms responsible for the long-term consequences of fetal glucocorticoid exposure in adulthood.

Indexed as

AnimalsDexamethasoneEmbryonic Stem CellsGlucocorticoidsHypothalamusMiceNeural Stem CellsTranscriptomeDexamethasoneGlucocorticoids

Identifiers

PMID26606517
PMCPMC4695633
OpenAlexW2177832526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.